Key drivers include Breztri Aerosphere (budesonide, formoterol fumarate, and glycopyrrolate) and Fasenra, both of which are positioned for indication expansions into severe asthma and COPD.
Key drivers include Breztri Aerosphere (budesonide, formoterol fumarate, and glycopyrrolate) and Fasenra, both of which are positioned for indication expansions into severe asthma and COPD. The first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback